To combat the silent pandemic of antibiotic resistance, the PROMISE professional meta-network was set up as part of the Priority Antibiotic Resistance Research Plan (INSERM and ANR). The emerging AntibioDEAL network is part of this program and aims to structure research and development into anti-infective agents at the national level and foster a collaborative environment.

AntibioDEAL's aims also to identify and remove the scientific and technological barriers to the discovery of anti-infective agents, and thus jump-start the preclinical pipeline, a public health priority. AntibioDEAL already boasts a directory of over 140 researchers eager to participate in and contribute to the structuring and influence of French research in the field of anti-infective agents and antibiotic resistance.

The AntibioDEAL days will bring together national experts developing anti-infective agents, from discovery to pre-clinical evaluation.

We are looking forward to welcoming you to Kremlin-Bicêtre, Paris!